GLP-1 Peptide Impurity Library

GLP-1 and Metabolic Peptide Research

GLP-1 Peptide Impurity Library

Custom Semaglutide, Retatrutide and Tirzepatide impurity peptides for analytical method development, HPLC and LC-MS comparison, stability investigations, forced-degradation research and related-substance studies.

Custom Peptide Impurities for Analytical Research

Peptide-related impurities may differ from the intended parent peptide by stereochemistry, amino-acid sequence, oxidation state, side-chain structure, linker composition, acylation pattern or terminal processing. These variants may arise during synthesis and purification or may be generated during handling, storage and stress studies.

LifeTein provides individually synthesized impurity peptides for research programs that require defined, sequence-specific materials. Projects can be reviewed according to the requested sequence, purity, quantity, salt form, analytical package and intended research use.

Important scope: These catalog entries are custom, research-use-only peptides. They are not represented as compendial, pharmacopoeial or certified reference standards unless a project quotation expressly includes an agreed reference-material qualification package.

Browse the GLP-1 Impurity Libraries

Semaglutide Impurity Peptides

105 listed variants

Sequence-related, stereochemical, degradation-related and lipidation-associated Semaglutide research peptides.

Browse Semaglutide impurities

Retatrutide Impurity Peptides

122 listed variants

Custom impurity peptides related to the long, modified and lipidated Retatrutide sequence.

Browse Retatrutide impurities

Tirzepatide Impurity Peptides

124 listed variants

Tirzepatide stereochemical, sequence-related, linker-related and degradation-related research peptides.

Browse Tirzepatide impurities

Common Classes of Peptide-Related Impurities

D-Amino-Acid Variants

Stereochemical variants in which an intended L-residue is replaced by the corresponding D-residue or another stereoisomer.

Deletion and Truncation Variants

Peptides lacking one or more residues or containing incomplete N-terminal or C-terminal sequence regions.

Aspartyl Rearrangement Variants

Defined Asp-related isomers, including β-aspartyl or isoaspartyl-type sequence variants where applicable.

Oxidation and Degradation Variants

Oxidized or otherwise transformed peptides prepared for comparison in analytical and stability-related research.

Substitution Variants

Sequence variants containing a specified amino-acid replacement at a defined position.

Linker and Lipidation Variants

Peptides with altered spacer, linker, conjugation or fatty-acid components relative to the parent sequence.

Terminal Variants

Peptides with specified changes in N-terminal or C-terminal processing, protection or sequence length.

Custom Related Substances

Project-specific sequences proposed by a customer for feasibility review and custom synthesis.

Research and Analytical Applications

Application How a Defined Impurity Peptide May Be Used
HPLC or UPLC method development Evaluate chromatographic separation and retention behavior.
LC-MS comparison Support mass, retention-time and fragmentation comparison.
Related-substance investigations Examine a proposed sequence-related or chemically modified variant.
Forced-degradation research Compare stress-study peaks with defined candidate materials.
Stability-method research Support development or evaluation of stability-indicating procedures.
Process-development research Investigate process-related peptide variants during synthesis or purification studies.

LifeTein Peptide Synthesis Capabilities

LifeTein is a New Jersey-based CRO founded in 2008. The company supports custom peptide projects ranging from short peptides to long and modified sequences. Current LifeTein service information lists peptide lengths from 2 to 170 amino acids, multiple purity options, broad modification support, preparative purification, analytical HPLC and mass-spectrometry confirmation.

Challenging Sequences

Technical review for long, hydrophobic, repetitive and heavily modified sequences.

Flexible Specifications

Selectable quantity, purity, salt form and project-specific analytical requirements.

Analytical Documentation

Analytical HPLC, mass-spectrometry confirmation and supporting documentation according to the quoted package.

Custom Synthesis Workflow

1. Submit

Provide the catalog number, sequence or proposed structural variant.

2. Review

LifeTein evaluates sequence complexity, scale, purity and analytical needs.

3. Synthesize

The peptide is synthesized and purified according to the accepted quotation.

4. Analyze

Agreed HPLC, MS and documentation are prepared for delivery.

Related LifeTein Services

Frequently Asked Questions

Are these products certified reference standards?

No general claim of compendial or certified-reference-standard status is made. They are custom research peptides unless a separate, project-specific qualification package is expressly agreed.

Can LifeTein synthesize an impurity that is not listed?

Yes. Submit the proposed sequence or structural change for feasibility review, pricing and lead-time evaluation.

Can purity and quantity be customized?

Yes. Available purity, scale and analytical options depend on the sequence and project requirements.

Are HPLC and mass-spectrometry data available?

Analytical HPLC and mass-spectrometry confirmation can be included according to the quotation.

Can a different salt form be requested?

Salt-form or counterion requirements can be reviewed during quotation.

How should I request a quote?

Provide the catalog number or sequence, quantity, purity, salt form, analytical requirements and intended research application.

Scientific and Regulatory Context

Defined peptide-related materials may support analytical procedure development and comparison studies. The appropriate use, qualification, acceptance criteria and regulatory suitability remain the responsibility of the customer and depend on the intended application.

  1. U.S. FDA. Guidance for Industry: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin.
  2. ICH Q2(R2). Validation of Analytical Procedures.
  3. ICH Q1A(R2). Stability Testing of New Drug Substances and Products.

Request a GLP-1 Impurity Peptide Quote

Send the catalog number or sequence together with the desired quantity, purity, salt form and analytical package. Unlisted candidate impurities can also be reviewed.

Request a Quote

For research use only. Not for human, veterinary, diagnostic, therapeutic or clinical use.